IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination-Reference-Cited by-同舟云学术

IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination

Published:2023-10-28 Issue: Volume: Page:
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Muñoz-Gómez María José,Martin-Vicente María,Vigil-Vazquez Sara,Carrasco Itziar,Lobo Alicia Hernanz,Mas Vicente,Vázquez Mónica,Manzanares Angela,Cano Olga,Zamora Clara,Alonso Roberto,Sepulveda-Crespo Daniel,Tarancon-Diez Laura,Muñoz-Fernández María Ángeles,Muñoz-Chapuli Mar,Resino Salvador,Navarro Maria Luisa,Martinez Isidoro

Funder

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina

Centro de Investigación Biomédica en Red de Enfermedades Infecciosas

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s15010-023-02111-x.pdf

Reference61 articles.

1. Korang SK, von Rohden E, Veroniki AA, Ong G, Ngalamika O, Siddiqui F, et al. Vaccines to prevent COVID-19: a living systematic review with trial sequential analysis and network meta-analysis of randomized clinical trials. PLoS ONE. 2022;17(1): e0260733. https://doi.org/10.1371/journal.pone.0260733.

2. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-92 e6. https://doi.org/10.1016/j.cell.2020.02.058.